Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
1234
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Chronic Liver Disease and Cirrhosis 2019 NHLBI 1K22HL135075-01 Dietary factors, biomarkers, metabolic pathways related to non-alcoholic fatty liver disease MA, JIANTAO TUFTS UNIVERSITY BOSTON MA $249,000
Chronic Liver Disease and Cirrhosis 2019 NHLBI 5U01HL121842-03 Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease BYRNE, BARRY UNIVERSITY OF FLORIDA FL $403,073
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA033862-06 Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD HAVENS, JENNIFER UNIVERSITY OF KENTUCKY KY $537,587
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA026770-09 Early-Stage Chronic Kidney Disease in HIV-infected Individuals LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $625,114
Chronic Liver Disease and Cirrhosis 2019 NIA 5P01AG005842-31 8055 1 -Understanding Recent Trends in Mortality and Morbidity CASE, ANNE NATIONAL BUREAU OF ECONOMIC RESEARCH MA $163,068
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK104893-04 Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis ZHOU, HUIPING VIRGINIA COMMONWEALTH UNIVERSITY VA $393,548
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI136715-02 HIV, HCV, Hippo, and Liver Disease Progression CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $714,134
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI127463-03 Mechanisms of hepatic innate immune activation by HCV GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $539,963
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI078881-09 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $531,382
Chronic Liver Disease and Cirrhosis 2019 NIAID 5K08AI121348-04 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $199,314
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK107643-04 Mechanism of SREBP Cleavage Activating Protein Golgi-to-ER Recycling ESPENSHADE, PETER JOHNS HOPKINS UNIVERSITY MD $291,600
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK105033-04 Novel mechanisms of UPR sensing and nonalcoholic fatty liver disease LI, ZIHAI MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $336,375
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI114748-05 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K08DK099412-05 The role of macrophage migration inhibitory factor in autoimmune hepatitis ASSIS, DAVID YALE UNIVERSITY CT $168,588
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK113272-02 Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI TAOULI, BACHIR ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $526,905
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI136626-02 Changes in Bone Quality, Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $794,282
Chronic Liver Disease and Cirrhosis 2019 NIA 5R01AG055636-02 Use of New Hepatitis C Drugs and Patients' Health Outcomes in Medicare JUNG, JEAH PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $480,581
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK105434-04 Investigating Autophagy in GSD-Ia KOEBERL, DWIGHT DUKE UNIVERSITY NC $320,742
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R03DK113339-02 Epigenetic Regulation in Primary Sclerosing Cholangitis HUEBERT, ROBERT MAYO CLINIC ROCHESTER MN $79,500
Chronic Liver Disease and Cirrhosis 2019 NIAAA 2P50AA011999-21 5316 Administrative Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $353,935
Chronic Liver Disease and Cirrhosis 2019 NIAAA 2P50AA011999-21 5317 Animal Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $445,191
Chronic Liver Disease and Cirrhosis 2019 NIAAA 2P50AA011999-21 5318 Pilot Project Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $191,120
Chronic Liver Disease and Cirrhosis 2019 NIAAA 2P50AA011999-21 5319 Research Project 1: The CASP4/11-GSDMD Pathway in Alcoholic Hepatitis TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $176,299
Chronic Liver Disease and Cirrhosis 2019 NIAAA 2P50AA011999-21 5320 Research Project 2: Genome-wide epigenetic changes regulating specific transcription factors determine HSC phenotype in alcohol-induced liver fibrosis TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $114,000
Chronic Liver Disease and Cirrhosis 2019 NIAAA 2P50AA011999-21 5321 Research Project 3: Cell fate decision of liver tumor-initiating stem-like cells induced by alcohol MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $133,643
Chronic Liver Disease and Cirrhosis 2019 NIAAA 2P50AA011999-21 5322 Research Project 4: NF-κB–NRF2 Interplay Regulates Inflammation in Alcoholic Pancreatitis TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $135,043
Chronic Liver Disease and Cirrhosis 2019 NIBIB 5R21EB024135-02 Pioneering regenerative surgery - Mechanisms of cell death and regeneration in liver treated with non-thermal irreversible electroporation (NTIRE) CHANG, TAMMY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $198,125
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1P50AA027054-01 5359 Administrative Core CAMERON, ANDREW JOHNS HOPKINS UNIVERSITY MD $88,424
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1P50AA027054-01 5360 Pathology Core ANDERS, ROBERT JOHNS HOPKINS UNIVERSITY MD $125,753
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1P50AA027054-01 5361 Project 1-Cohort and Ethical Analysis of Patients undergoing Early Liver Transplant for Severe Alcoholic Hepatitis CAMERON, ANDREW JOHNS HOPKINS UNIVERSITY MD $353,700
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1P50AA027054-01 5362 Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions MCCAUL, MARY JOHNS HOPKINS UNIVERSITY MD $406,763
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1P50AA027054-01 5363 Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens ZHU, HENG JOHNS HOPKINS UNIVERSITY MD $353,698
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1P50AA027054-01 5364 Project 4-Animal transplant models to characterize immune and regenerative effects of alcohol SUN, ZHAOLI JOHNS HOPKINS UNIVERSITY MD $353,703
Chronic Liver Disease and Cirrhosis 2019 NHLBI 5R01HL134853-03 Trib1 regulation of hepatic lipid metabolism and atherogenesis RADER, DANIEL UNIVERSITY OF PENNSYLVANIA PA $402,500
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI136533-02 Dynamics of antigen specific B and Tfh responses during acute and chronic HCV GRAKOUI, ARASH EMORY UNIVERSITY GA $794,050
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA222570-02 Serotonergic antidepressants as liver tumor preventives EVASON, KIMBERLEY UNIVERSITY OF UTAH UT $338,378
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK108357-04 Tissue Responses to Metabolic Stress SCHAFFER, JEAN WASHINGTON UNIVERSITY MO $479,260
Chronic Liver Disease and Cirrhosis 2019 NINR 5R01NR016017-04 Symptom burden in End-Stage Liver Disease patient-caregiver dyads HANSEN, LISSI OREGON HEALTH & SCIENCE UNIVERSITY OR $385,000
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5R01GM101502-06 Integrative Analysis of Wilson's Disease LUTSENKO, SVETLANA JOHNS HOPKINS UNIVERSITY MD $428,211
Chronic Liver Disease and Cirrhosis 2019 NHLBI 5R35HL135833-03 Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men GINSBERG, HENRY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $953,882
Chronic Liver Disease and Cirrhosis 2019 NIMHD 2U54MD007597-31 5949 Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population GHOSH, SOMIRANJAN HOWARD UNIVERSITY DC $296,288
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5R01GM121550-02 Function and Regulation of SLC13A5 in the Liver WANG, HONGBING UNIVERSITY OF MARYLAND BALTIMORE MD $297,413
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R01AA022986-05 CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease AVADHANI, NARAYAN UNIVERSITY OF PENNSYLVANIA PA $520,771
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK116620-02 TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications TABAS, IRA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $664,138
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA190844-05 Hepatic Stellate Cells and Liver Cancer SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $346,048
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA222900-02 Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis SINGAL, AMIT UT SOUTHWESTERN MEDICAL CENTER TX $483,382
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI125365-03 Analyses of the Antiviral and Antifibrotic Mechanisms of Action of NS5A and Cyclophilin Inhibitors GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $481,250
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5F32DK114954-02 Effect of Liver-Specific Acetyl-CoA Carboxylase Inhibition on Hepatic Steatosis and Insulin Resistance GOEDEKE, LEIGH YALE UNIVERSITY CT $64,046
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA193244-09 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $507,552
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK111866-03 Fibrocytes regulate liver fibrosis KISSELEVA, TATIANA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $348,750
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA211794-03 Role of p62/SQSTM1 in obesity-induced liver cancer KARIN, MICHAEL UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $704,458
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K23DK109207-03 Assessment of a Novel Newborn Screening Tool for Biliary Atresia HARPAVAT, SANJIV BAYLOR COLLEGE OF MEDICINE TX $180,355
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K23DK113252-02 Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community LONG, MICHELLE BOSTON MEDICAL CENTER MA $191,160
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK083355-09 Mechanisms of bile duct reprogramming STANGER, BEN UNIVERSITY OF PENNSYLVANIA PA $507,802
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI065256-09 HIV Antiretroviral Therapy and Hepatic Injury SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $500,044
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5K23AA023753-05 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $199,800
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5P30DK097948-05 5072 Biorepository Core FIOCCHI, CLAUDIO CASE WESTERN RESERVE UNIVERSITY OH $221,155
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R01AA017729-08 Innate immune signaling in alcoholic liver disease SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $136,312
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI120622-04 Restoration of immunity and function with DAA treatment in HCV infection ROSEN, HUGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,500
Chronic Liver Disease and Cirrhosis 2019 NIGMS 1P20GM130461-01 5442 Capturing Rural Risk Network Structures from Continuous-time Interaction Data (RISC) SMITH, JEFFREY UNIVERSITY OF NEBRASKA LINCOLN NE $235,463
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K01DK115525-02 Hepatocyte PPARgamma regulated mechanisms in NAFLD and lipid homeostasis CORDOBA-CHACON, JOSE UNIVERSITY OF ILLINOIS AT CHICAGO IL $136,521
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK074932-13 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Chronic Liver Disease and Cirrhosis 2019 NHLBI 2P01HL120840-06 6285 Pannexin 1 channels in diet-induced metabolic syndrome LEITINGER, NORBERT UNIVERSITY OF VIRGINIA VA $403,750
Chronic Liver Disease and Cirrhosis 2019 NIGMS 1SC2GM125551-01A1 Role of CARF in Insulin Resistance and Non Alcoholic Fatty Liver disease NAFLD HASAN, KAMRUL CHARLES R. DREW UNIVERSITY OF MED & SCI CA $143,500
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R21AI138165-02 Ischemia / Reperfusion Injury Mediated TIM-3+CD4+ T Cell Exhaustion In Liver Transplant JI, HAOFENG UNIVERSITY OF CALIFORNIA LOS ANGELES CA $234,000
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI124006-04 Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines ROBEK, MICHAEL ALBANY MEDICAL COLLEGE NY $399,750
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R21AI133632-02 Creation of a chronic HBV infection model in rhesus macaques BURWITZ, BENJAMIN OREGON HEALTH & SCIENCE UNIVERSITY OR $253,124
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK107535-05 Regulation of Lipid Storage by mTORC1 BRIDGES, DAVE UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $351,000
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R44DK116635-03 Noninvasive urinary monitoring of NASH by activity-based nanosensors HUANG, ERIC GLYMPSE BIO, INC. MA $923,177
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K01DK111716-03 Nuclear Receptors as Novel Therapeutic Targets for Wilson’s Disease WOOTON-KEE, CLAVIA BAYLOR COLLEGE OF MEDICINE TX $148,956
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI116639-05 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Chronic Liver Disease and Cirrhosis 2019 NIAID 6R01AI116868-04 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY TRIAD NATIONAL SECURITY, LLC NM $805,759
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI137567-02 Host response and liver disease in a hepatitis C-like virus rat model KAPOOR, AMIT RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $507,238
Chronic Liver Disease and Cirrhosis 2019 NCI 5F30CA216947-02 Investigating the Relationship Between Racial Residential Segregation and Hepatocellular Carcinoma BEMANIAN, AMIN MEDICAL COLLEGE OF WISCONSIN WI $50,016
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1R21AA027222-01 Roles of lysophosphatidic acid in alcoholic liver disease ASAHINA, KINJI UNIVERSITY OF SOUTHERN CALIFORNIA CA $237,188
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK109102-05 Estrogen and Coordinated Carbohydrate and Lipid Metabolism in Obesity STAFFORD, JOHN VANDERBILT UNIVERSITY MEDICAL CENTER TN $355,500
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK119147-01 Lymphatic remodeling and transport of dietary fats in short gut syndrome RANDOLPH, GWENDALYN WASHINGTON UNIVERSITY MO $438,294
Chronic Liver Disease and Cirrhosis 2019 NCI 1R01CA233794-01 Reverse-engineering precision liver cancer chemoprevention HOSHIDA, YUJIN UT SOUTHWESTERN MEDICAL CENTER TX $653,924
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K01DK112915-02 Regulation of Hepatic Fibrogeneiss by TANGO1 MAIERS, JESSICA MAYO CLINIC ROCHESTER MN $146,459
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK119860-01 Development of a Machine Learning Model to Integrate Clinical, Laboratory, Sonographic, and Elastographic Data for Noninvasive Liver Tissue Characterization in NAFLD SAMIR, ANTHONY MASSACHUSETTS GENERAL HOSPITAL MA $462,750
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK119913-01 Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease MCCLAIN, DONALD WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $680,226
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK119627-01 Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD JURCZAK, MICHAEL UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $408,615
Chronic Liver Disease and Cirrhosis 2019 NCI 1R01CA234128-01 Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors KARIN, MICHAEL UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $550,740
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1U01DK119702-01 R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease PATTERSON, ANDREW PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $368,652
Chronic Liver Disease and Cirrhosis 2019 NCI 1R01CA233878-01 Yittrium-90 radiation lobectomy: Dose optimization and prediction of FLR hypertrophy to enable resection of HCC LEWANDOWSKI, ROBERT NORTHWESTERN UNIVERSITY AT CHICAGO IL $626,909
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R21AI135849-02 Defining the biology and public health risk of HBV Genotype E UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $190,364
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK112295-03 Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV NAGGIE, SUSANNA DUKE UNIVERSITY NC $391,834
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K01DK109025-03 MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease THAPA, MANOJ EMORY UNIVERSITY GA $100,781
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK078184-11 Factors Controlling Metabolic Flux in the Liver BURGESS, SHAWN UT SOUTHWESTERN MEDICAL CENTER TX $405,000
Chronic Liver Disease and Cirrhosis 2019 NCI 1U01CA226052-01A1 Glycopathology of HCC: identification of the source cells of serum fucosylation MEHTA, ANAND MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $552,594
Chronic Liver Disease and Cirrhosis 2019 NICHD 5R01HD041230-15 Prenatal Metabolic Programming of the Offspring DEVASKAR, SHERIN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI110762-04 Molecular Mechanisms of HBV cccDNA Formation GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $393,750
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI131688-03 Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection RICE, CHARLES ROCKEFELLER UNIVERSITY NY $624,270
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK115747-02 Elucidating chemo-mechanical determinants of human hepatocyte and stellate cell responses in non-alcoholic fatty liver disease KHETANI, SALMAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $345,284
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK110035-03 Neuroendocrine Regulation of Biliary Growth and Fibrosis GLASER, SHANNON TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $286,472
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK114041-02 Ca2+ waves in hepatocytes: Mechanisms and effects NATHANSON, MICHAEL YALE UNIVERSITY CT $519,087
Chronic Liver Disease and Cirrhosis 2019 NIEHS 1R01ES028668-01A1 Renal Disposition in NASH CHERRINGTON, NATHAN UNIVERSITY OF ARIZONA AZ $497,068
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5F31DK115029-02 Race/Ethnic Specific Association Between Anthropometry, Liver Fat and Incident Type 2 Diabetes: Evidence from The Multi-Ethnic Study of Atherosclerosis RODRIGUEZ, LUIS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $36,721
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K23DK115682-02 Improving Diagnosis and Prevention of Pediatric Nonalcoholic Fatty Liver Disease WOO BAIDAL, JENNIFER COLUMBIA UNIVERSITY HEALTH SCIENCES NY $193,455
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK116774-02 Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1 SHULMAN, GERALD YALE UNIVERSITY CT $418,750
Chronic Liver Disease and Cirrhosis 2019 NCI 5R00CA191152-05 Development of mosaic mouse models of HCC for genetic interspecies inference FONT-BURGADA, JOAN RESEARCH INST OF FOX CHASE CAN CTR PA $249,000
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA042982-02 The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial HAUKOOS, JASON DENVER HEALTH AND HOSPITAL AUTHORITY CO $598,750
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R03DK119636-01 Dysregulation of Hepatic Energy Metabolism in Argininosuccinate Lyase Deficiency BURRAGE, LINDSAY BAYLOR COLLEGE OF MEDICINE TX $119,719
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA044111-03 Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $694,955
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK067215-14 Cellular Mechanisms of Hepatotoxicity. KAPLOWITZ, NEIL UNIVERSITY OF SOUTHERN CALIFORNIA CA $476,495
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K23DK115594-02 Noninvasive detection of NASH by magnetic resonance elastography (MRE) ALLEN, ALINA MAYO CLINIC ROCHESTER MN $169,128
Chronic Liver Disease and Cirrhosis 2019 NICHD 1R21HD097558-01 Targeted Proteomic Analysis of Extremely Low Abundance Signature Peptide Biomarkers for Potential Newborn Screening in Wilson's Disease HAHN, SIHOUN SEATTLE CHILDREN'S HOSPITAL WA $282,450
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI110358-05 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MED BR GALVESTON TX $387,500
Chronic Liver Disease and Cirrhosis 2019 NCI 5R21CA225623-02 Identification of microbial biomarkers for hepatocellular carcinoma in a multi-ethnic population of patients with nonalcoholic fatty liver disease HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $182,141
Chronic Liver Disease and Cirrhosis 2019 NHLBI 5R01HL107794-09 Control Sterol and Lipoprotein Homeostasis by miRNA BALDAN, ANGEL SAINT LOUIS UNIVERSITY MO $351,898
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK119767-01 Jagged-Notch signaling in NASH/fibrosis PAJVANI, UTPAL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $415,175
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1R21AA027367-01 The Role of TP-R on Adipose Tissue Browning: Therapeutic Implications in Alcoholic and Non-Alcoholic Fatty Liver Disease VISWANATHAN, SARASWATHI UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $184,496
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI134630-03 Mediators of fatty liver disease during HIV/SIV and cART treatment SODORA, DONALD SEATTLE CHILDREN'S HOSPITAL WA $893,138
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA200310-04 Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma MACLEOD, KAY UNIVERSITY OF CHICAGO IL $385,645
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK110355-03 CD73 is a multi-functional protein that regulates liver injury SNIDER, NATASHA UNIV OF NORTH CAROLINA CHAPEL HILL NC $344,347
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK113592-03 Sterile inflammation and pyroptotic cell death in liver fibrosis FELDSTEIN, ARIEL UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $494,042
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5F30DK117615-02 Neuregulin-4 Signaling in Hepatocytes Defines an Endocrine Checkpoint for NASH and HCC Progression KUANG, HENRY UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $40,567
Chronic Liver Disease and Cirrhosis 2019 NICHD 5R01HD092527-02 Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection JOURDAIN, GONZAGUE INSTITUTE OF RESEARCH AND DEVELOPMENT FR $445,447
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI122369-04 Hepatocyte xenografts for treatment of acute liver failure FOX, IRA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $1,006,195
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R21AI133250-02 Development of a hepatitis C virus vaccine using papillomavirus-like particles for antigen delivery QIAO, LIANG LOYOLA UNIVERSITY CHICAGO IL $221,844
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK062357-14 NRF2 - SIRT1 SIGNALING AXIS IN LIVER TRANSPLANT REJUVENATION KUPIEC-WEGLINSKI, JERZY UNIVERSITY OF CALIFORNIA LOS ANGELES CA $426,948
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI118916-04 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $507,805
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK103185-05 Homeostatic Role of IRE1a-XBP1-PDI1 in Hepatic Lipid Metabolism KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $585,000
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K23DK115897-02 Developing technology-based approaches to improve access and quality of care in cirrhosis SERPER, MARINA UNIVERSITY OF PENNSYLVANIA PA $194,899
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5R21ES029258-02 Differential roles of FXR and FGF15 in liver fibrosis development GUO, GRACE RUTGERS, THE STATE UNIV OF N.J. NJ $193,750
Chronic Liver Disease and Cirrhosis 2019 NCI 1R03CA235109-01 Validation of an Advanced Magnetic Resonance Imaging Protocol for Tracking Liver Cancer and Cirrhosis in a Transgenic Porcine Tumorigenic Platform GABA, RON UNIVERSITY OF ILLINOIS AT CHICAGO IL $79,950
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5F31DK113665-02 Leucine Sensing by the mTORC1 Pathway in the Liver CANGELOSI, ANDREW MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $45,016
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5K01AA024174-04 Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease PI, LIYA UNIVERSITY OF FLORIDA FL $145,057
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA200597-04 HMGB1 as Link Between Hepatocellular Injury and HCC SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $430,447
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA040488-04 RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression LATKIN, CARL JOHNS HOPKINS UNIVERSITY MD $643,731
Chronic Liver Disease and Cirrhosis 2019 NCI 1R01CA226281-01A1 The Long Noncoding RNA MALAT1 in Liver Cancer WU, TONG TULANE UNIVERSITY OF LOUISIANA LA $345,222
Chronic Liver Disease and Cirrhosis 2019 NCI 1R37CA225807-01A1 Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease SHIN, SOONA CINCINNATI CHILDRENS HOSP MED CTR OH $363,713
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK110167-03 Relaxin receptor agonists for treatment of liver fibrosis AGOULNIK, ALEXANDER FLORIDA INTERNATIONAL UNIVERSITY FL $437,423
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R44DK115242-03 Development and validation of a novel 3D human in vitro model of nonalcoholic steatohepatitis to be used for novel therapeutic screening and research on disease mechanism. CHEN, ALICE ORGANOVO, INC. CA $653,558
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA046277-02 T cells in HCV/HIV co-infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $648,499
Chronic Liver Disease and Cirrhosis 2019 NIAID 5U19AI088791-09 6464 Scientific Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $399,173
Chronic Liver Disease and Cirrhosis 2019 NIAID 5U19AI088791-09 6466 Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $188,591
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K08DK111397-03 Mentored Clinical Scientist Research Career Development (K08) research grant IBRAHIM, SAMAR MAYO CLINIC ROCHESTER MN $165,456
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK104735-05 TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITIS FINCK, BRIAN WASHINGTON UNIVERSITY MO $418,815
Chronic Liver Disease and Cirrhosis 2019 NHLBI 2R01HL077588-15 Regulation of Cellular Cholesterol Homeostasis ESPENSHADE, PETER JOHNS HOPKINS UNIVERSITY MD $481,283
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK109365-03 Mapping Disease Pathways for Biliary Atresia SINDHI, RAKESH UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $592,433
Chronic Liver Disease and Cirrhosis 2019 NIDDK 2R01DK091566-06A1 Genetic basis of virus induced Biliary Atresia TIAO, GREGORY CINCINNATI CHILDRENS HOSP MED CTR OH $455,692
Chronic Liver Disease and Cirrhosis 2019 NCI 1R01CA226528-01A1 Tumor Detection and Classification using QUS Technology's Structure Function O'BRIEN, WILLIAM UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $500,727
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK117076-01A1 Molecular Regulation of Hepatocyte Proliferation and Liver Regeneration DAI, GUOLI INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $354,375
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK116126-01A1 QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload WANG, YI WEILL MEDICAL COLL OF CORNELL UNIV NY $538,134
Chronic Liver Disease and Cirrhosis 2019 NCI 5R21CA228089-02 Etheno Adducts in Liver Cancer PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE MI $200,425
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA228589-02 Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations SETIAWAN, VERONICA UNIVERSITY OF SOUTHERN CALIFORNIA CA $494,016
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA043409-03 Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention HERBECK, JOSHUA UNIVERSITY OF WASHINGTON WA $606,805
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK102667-05 Innovative Genetic Approaches for Hepatic Repopulation KAESTNER, KLAUS UNIVERSITY OF PENNSYLVANIA PA $360,000
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5R01GM120196-03 Endocytic Trafficking and Cell Signaling in Models of ARC Syndrome KRAMER, HELMUT UT SOUTHWESTERN MEDICAL CENTER TX $332,100
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK105517-04 Physiologic Consequence of Genetic Variation WATANABE, RICHARD UNIVERSITY OF SOUTHERN CALIFORNIA CA $769,738
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK102110-05 Tim Costimulation in Liver Transplant Ischemia Injury KUPIEC-WEGLINSKI, JERZY UNIVERSITY OF CALIFORNIA LOS ANGELES CA $346,500
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1K23DK117055-01A1 Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy TAPPER, ELLIOT UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $193,640
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK041876-31 Mechanisms of Liver Cell Injury GORES, GREGORY MAYO CLINIC ROCHESTER MN $357,750
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK091538-11 Ketone Body Metabolism and Integrated Metabolic Homeostasis CRAWFORD, PETER UNIVERSITY OF MINNESOTA MN $382,595
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA044971-02 Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission DICKSON-GOMEZ, JULIA MEDICAL COLLEGE OF WISCONSIN WI $570,636
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK109096-05 Regulation of Hepatic Lipid Accumulation and Insulin Resistance LIU, JUN MAYO CLINIC ROCHESTER MN $357,750
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK119968-01 Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates SHULMAN, GERALD YALE UNIVERSITY CT $557,732
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK117133-01A1 The Development of TGR5 Antagonists for the Treatment of Cholangiopathies PINKERTON, ANTHONY SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $537,612
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK104956-05 Molecular Imaging of Liver Fibrosis TANABE, KENNETH MASSACHUSETTS GENERAL HOSPITAL MA $527,284
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK108743-04 Control of stellate cells-driven liver cancer by the p62/NBR1 adapters MOSCAT, JORGE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $433,352
Chronic Liver Disease and Cirrhosis 2019 NIAAA 1R21AA026629-01A1 Sphingosine-1 phosphate signaling in alcoholic liver disease ZHOU, HUIPING VIRGINIA COMMONWEALTH UNIVERSITY VA $223,112
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R21AA025429-02 Role of Exosomal microRNAs in Alcohol-induced Liver Injury MCKILLOP, IAIN CAROLINAS MEDICAL CENTER NC $184,063
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R21DK117431-01A1 Evaluating a novel, portable, self-administered device ("Flicker-App") that measures critical flicker frequency as a test for minimal hepatic encephalopathy in cirrhosis IOANNOU, GEORGE SEATTLE INST FOR BIOMEDICAL/CLINICAL RES WA $220,626
Chronic Liver Disease and Cirrhosis 2019 NIAID 5U19AI123862-04 6262 Humoral immunity against hepatitis C in protected subjects FOUNG, STEVEN STANFORD UNIVERSITY CA $706,054
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK114282-02 A New Molecular Mechanism to Bioengineering a Liver LAGASSE, ERIC UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $417,262
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R03DK117249-02 Defining the role of MIF and CD74 in autoimmune cholangitis ASSIS, DAVID YALE UNIVERSITY CT $125,625
Chronic Liver Disease and Cirrhosis 2019 NHLBI 2R01HL119830-05 TTC39B in Metabolism TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $486,000
Chronic Liver Disease and Cirrhosis 2019 NCI 5F32CA225145-02 Engineering of bacterial probiotics for the detection and treatment of hepatocellular carcinoma SINGER, ZAKARY COLUMBIA UNIV NEW YORK MORNINGSIDE NY $62,746
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5F30DK116529-02 ABHD5 and PNPLA3 in the development of fatty liver disease YANG, ALEXANDER WAYNE STATE UNIVERSITY MI $38,920
Chronic Liver Disease and Cirrhosis 2019 NCI 5R21CA215883-02 Assessment of gene expression profiles related to hepatocellular carcinoma in HCV: singlecell hepatocyte sequencing as a tool to identify cancer-related genes DEBES, JOSE UNIVERSITY OF MINNESOTA MN $194,940
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI095690-09 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK112865-03 Metabolic Origins of Nonalcoholic Steatohepatitis SUNNY, NISHANTH UNIV OF MARYLAND, COLLEGE PARK MD $342,000
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK108891-04 HGF/HGFR Axis and Fatty Liver Disease ZARNEGAR, REZA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $352,125
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R21AA025730-02 Alcohol Biosensor Monitoring for Alcoholic Liver Disease DIMARTINI, ANDREA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $145,936
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI120733-04 The Impact of HCV Infection on Bone Turnover, Density, and Strength BROWN, TODD JOHNS HOPKINS UNIVERSITY MD $718,442
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK083952-09 The AHR-FGF221 Axis in Hepatic Steatosis and Metobolic Syndrome XIE, WEN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $352,125
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK110273-03 R-spondin1-LGR4 Signaling and Ischemia/Reperfusion Injury in Steatotic Liver MULHOLLAND, MICHAEL UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $411,384
Chronic Liver Disease and Cirrhosis 2019 NIAID 5U19AI123861-04 6293 Antibody responses to HCV vaccine antigens in infection and vaccination LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $426,357
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA204665-02 Genomics of HCC in the Hispanic population of Texas BERETTA, LAURA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $349,864
Chronic Liver Disease and Cirrhosis 2019 NIDA 5K24DA034621-07 Midcareer Investigator Award in Patient-Oriented Research (Parent K24) SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $122,036
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK113645-03 Hepatitis C virus infection and mechanism of liver disease progression RAY, RANJIT SAINT LOUIS UNIVERSITY MO $340,875
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K08DK105351-06 Hippo Signaling Mediates the Development of Liver Fibrosis YIMLAMAI, DEAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $161,892
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R01AA011576-18 Alcohol and Monocyte Signaling SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $182,379
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK095842-07 Coordination of gut-liver bile acid signaling by FXR KEMPER, JONGSOOK UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $356,850
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK044650-28 Cytoskeletal Regulation Of Vesicle Transport In Liver MC NIVEN, MARK MAYO CLINIC ROCHESTER MN $357,750
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK062777-16 Regulation of Cholesterol Catabolism by Bile Acids KEMPER, JONGSOOK UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $396,500
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5R00ES024455-05 Microcystin-LR toxicity in nonalcoholic steatohepatitis CLARKE, JOHN WASHINGTON STATE UNIVERSITY WA $237,186
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK104770-04 Epigenetic regulation of Wilson Disease MEDICI, VALENTINA UNIVERSITY OF CALIFORNIA AT DAVIS CA $353,250
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5SC2GM127206-02 The treatment of Alcohol Liver Disease with Retinoid Beta Agonists TRASINO, STEVEN HUNTER COLLEGE NY $156,000
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES023716-03 5120 Environmental Exposure and Cardiometabolic Disease MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $212,377
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5F30DK108567-04 The role of SRSF1 in liver function and NASH ARIF, WAQAR UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $50,016
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K23DK113220-03 The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis DICHTEL, LAURA MASSACHUSETTS GENERAL HOSPITAL MA $198,297
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5P20GM113226-04 6168 Administrative Core MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $672,772
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5P20GM113226-04 6169 OMICS CORE ZHANG, XIANG UNIVERSITY OF LOUISVILLE KY $331,481
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5P20GM113226-04 6172 Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease KIRPICH, IRINA UNIVERSITY OF LOUISVILLE KY $167,465
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5P20GM113226-04 6173 Pathogenic role of PDE4 in hepatic stellate cell activation and TGF signaling GOBEJISHVILI, LEILA UNIVERSITY OF LOUISVILLE KY $174,430
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5P20GM113226-04 6175 Mechanisms of Probiotics in Alcoholic Liver Disease FENG, WENKE UNIVERSITY OF LOUISVILLE KY $173,756
Chronic Liver Disease and Cirrhosis 2019 NIGMS 5P20GM113226-04 6176 Effects of Dietary Fat on the Hepatotoxicity of Environmental Arsenic WATSON, WALTER UNIVERSITY OF LOUISVILLE KY $167,190
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA186566-05 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $602,699
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK112854-02 Predominant protective role in hepatic steatosis and obesity by fish oil-derived furans SCHOPFER, FRANCISCO UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $396,123
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK100314-05 NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling KOHLI, ROHIT CHILDREN'S HOSPITAL OF LOS ANGELES CA $482,124
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA188305-05 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $327,384
Chronic Liver Disease and Cirrhosis 2019 NIAID 2U19AI082630-11 7632 Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $720,185
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5K23DK102874-05 In vivo regulation of lipid flux in the etiology of NAFLD and Insulin Resistance VATNER, DANIEL YALE UNIVERSITY CT $162,216
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R01AA024726-03 The Role of the Intestinal Mycobiome in Alcoholic Liver Disease SCHNABL, BERND UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $327,904
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA190678-05 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $323,994
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI116269-05 Immune correlates of acute HBV recovery with and without HIV THIO, CHLOE JOHNS HOPKINS UNIVERSITY MD $611,631
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK117286-02 A Novel Stem Cell-based Approach for Generating Non-Human Primate Livers in Pigs STEER, CLIFFORD UNIVERSITY OF MINNESOTA MN $548,335
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R01AA025289-03 Targeting proteotoxic stress responses in liver fibrosis MANDREKAR, PRANOTI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $389,759
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI125401-04 Developmental regulation of HBV biosynthesis by FoxA and DNA methylation MCLACHLAN, ALAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,750
Chronic Liver Disease and Cirrhosis 2019 NCI 1R44CA228743-01A1 Early detection of HCC using noninvasive activity-based nanosensors HUANG, ERIC GLYMPSE BIO, INC. MA $291,191
Chronic Liver Disease and Cirrhosis 2019 NIMHD 1R01MD012579-01A1 Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics NAJJAR, SONIA OHIO UNIVERSITY ATHENS OH $613,874
Chronic Liver Disease and Cirrhosis 2019 NCI 1R01CA225478-01A1 Understanding the Multilevel Drivers of Liver Cancer Disparities SHARIFF-MARCO, SALMA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $680,549
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5P50AA024333-04 8232 Core C: Clinical Core MCCULLOUGH, ARTHUR CLEVELAND CLINIC LERNER COM-CWRU OH $168,148
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5P50AA024333-04 8234 Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury BROWN, JONATHAN CLEVELAND CLINIC LERNER COM-CWRU OH $249,638
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5P50AA024333-04 8235 Project 2: Lipin-1 and the development of ALD YOU, MIN CLEVELAND CLINIC LERNER COM-CWRU OH $238,770
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5P50AA024333-04 8236 Project 3: Sarcopenia of ALD: Regulation of Skeletal Muscle Autophagy by Alcohol DASARATHY, SRINIVASAN CLEVELAND CLINIC LERNER COM-CWRU OH $244,899
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5P50AA024333-04 8237 Project 4: Innate Immunity and Cell Death in ALD NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $249,638
Chronic Liver Disease and Cirrhosis 2019 NIAID 2R44AI088919-06A1 A therapeutic vaccine for chronic hepatitis B MILICH, DAVID VLP BIOTECH, INC. CA $878,409
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK108408-04 Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome JOHNSON, RICHARD UNIVERSITY OF COLORADO DENVER CO $415,684
Chronic Liver Disease and Cirrhosis 2019 NIAID 1F30AI143060-01 Hepacivirus control by vaccine-elicited T cells. HARTLAGE, ALEX RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $33,213
Chronic Liver Disease and Cirrhosis 2019 NCI 1F31CA228420-01A1 Deciphering cross-talk of signaling pathways in control of hepatocellular carcinogenesis HANLEY, KAISA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $37,891
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1U34DK120091-01 A trial of transplanting Hepatitis C kidneys into Hepatitis C-Negative kidney recipients REESE, PETER UNIVERSITY OF PENNSYLVANIA PA $362,250
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R01DK064008-15 Immunologic Dysfunction in Biliary Atresia BEZERRA, JORGE CINCINNATI CHILDRENS HOSP MED CTR OH $446,970
Chronic Liver Disease and Cirrhosis 2019 NCATS 1R13DK120294-01 Alagille Syndrome Scientific Meeting – Connecting the Pieces HUPPERT, STACEY CINCINNATI CHILDRENS HOSP MED CTR OH $3,000
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R13DK120294-01 Alagille Syndrome Scientific Meeting – Connecting the Pieces HUPPERT, STACEY CINCINNATI CHILDRENS HOSP MED CTR OH $7,000
Chronic Liver Disease and Cirrhosis 2019 OD 5R01DA044135-03 Regulatory T cell dysfunction in HIV-1/HCV drug users LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $199,650
Chronic Liver Disease and Cirrhosis 2019 NHLBI 5R01HL142341-02 Neural Regulation of Vasopressin Release in a Model of Dilutional Hyponatremia CUNNINGHAM, J UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $560,112
Chronic Liver Disease and Cirrhosis 2019 NIDDK 1R01DK118805-01A1 Hepatic FOXA3 Links NAFLD to Atherosclerosis ZHANG, YANQIAO NORTHEAST OHIO MEDICAL UNIVERSITY OH $511,155
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA158439-06 Monitoring and control of human liver cancer ablation using real-time, 3D echo decorrelation imaging MAST, T DOUGLAS UNIVERSITY OF CINCINNATI OH $342,753
Chronic Liver Disease and Cirrhosis 2019 NIDA 5K01DA045618-02 Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations PARK, HAESUK UNIVERSITY OF FLORIDA FL $130,075
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5189 Administrative Core TUKEY, ROBERT UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $67,550
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5190 Research Support Core: Genetics and Metabolomics MELLON, PAMELA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $270,476
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5191 Research Translation Core: Extending the Reach of Exposure Science and Technology That Improves the Detection and Remediation of Hazardous Substances PEZZOLI, KEITH UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $135,239
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5192 Community Engagement and Urban Agriculture: Addressing Concerns About Toxicants in Soil, Water and Plants PEZZOLI, KEITH UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $135,238
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5193 Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells KARIN, MICHAEL UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $304,284
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5194 Project 2: Nuclear Receptor Mediated Epigenetic and Immune Cell Changes in Liver Fibrosis Resulting From Toxicant Exposure EVANS, RONALD SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $365,108
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5195 Project 3: Molecular and Microbial Mechanisms Leading to Triclosan Induced Liver Fibrosis TUKEY, ROBERT UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $304,286
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5196 Project 4: The Role of Reactive Oxygen Species and the Microbiome in Toxicant Induced Liver Fibrosis BRENNER, DAVID UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $304,287
Chronic Liver Disease and Cirrhosis 2019 NIEHS 5P42ES010337-18 5946 Core-005: Training Core MELLON, PAMELA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $123,263
Chronic Liver Disease and Cirrhosis 2019 NCI 5R01CA198103-04 ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $640,385
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R37DA013806-20 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $733,577
Chronic Liver Disease and Cirrhosis 2019 NCI 1R21CA227023-01A1 Hepatocellular Carcinoma, Epigenetics and Cadmium Exposure HOYO, CATHRINE NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $246,698
Chronic Liver Disease and Cirrhosis 2019 NIDA 5R01DA042632-03 Primary role of Golgi stress in anti-HIV drug and alcohol abuse-induced hepatotoxicity JI, CHENG UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,500
Chronic Liver Disease and Cirrhosis 2019 NIDA 5K23DA044085-02 Engaging Young People who Inject Drugs into HCV and HIV Care ASSOUMOU, SABRINA BOSTON MEDICAL CENTER MA $187,212
Chronic Liver Disease and Cirrhosis 2019 NIDDK 5R37DK054488-19 Function of the hemochromatosis protein ENNS, CAROLINE OREGON HEALTH & SCIENCE UNIVERSITY OR $407,609
Chronic Liver Disease and Cirrhosis 2019 NCATS 5KL2TR001441-05 UTMB Clinical and Translational Science Award AMEREDES, BILL UNIVERSITY OF TEXAS MED BR GALVESTON TX $423,432
Chronic Liver Disease and Cirrhosis 2019 NIAAA 5R01AA020735-09 Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease CASEY, CAROL UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $568,021
Chronic Liver Disease and Cirrhosis 2019 NIAID 5R01AI129540-03 Hepatitis B virus e antigen in viral persistence OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,500
1234


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer